University Of Chicago
Clinical trials sponsored by University Of Chicago, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can your reaction to a drink predict future alcohol problems? Results expected Sep 2026 (estimated)
- Ice vs. High-Tech cool: which eases hand surgery pain best? Results expected Sep 2026 (estimated)
- New hope for young leukemia patients: targeted drug added to chemo Results expected Sep 2026 (estimated)
- Frequent anesthesia may increase risk of waking during surgery Results expected Sep 2026 (estimated)
- Nerve block may ease pain after broken knee surgery Results expected Sep 2026 (estimated)
-
Can a smaller dose of arthritis drug tame COVID-19 lung inflammation?
Disease control Stopped earlyThis study tested whether a low dose of tocilizumab, a drug used for arthritis, could help hospitalized COVID-19 patients with lung inflammation who were not on a breathing machine. The goal was to see if it sped up recovery and reduced deaths. The trial was stopped early, but re…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Experimental drug combo for head and neck cancer shows early promise
Disease control Stopped earlyThis early-stage trial tested an experimental drug called xevinapant combined with standard chemotherapy and radiation in people with head and neck cancer who cannot take the usual drug cisplatin. The goal was to find the safest dose of xevinapant. The study was terminated early,…
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Cancer drug trial stopped early: only 5 patients enrolled
Disease control Stopped earlyThis study tested the drug pembrolizumab in people with a hard-to-treat type of lymphoma (DLBCL) that has certain genetic changes in the PD-L1 gene. The goal was to see if the drug could shrink tumors. However, the study was stopped early after enrolling only 5 participants, so t…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Cancer drug combo shows promise but study halted early
Disease control Stopped earlyThis study tested a combination of two drugs—pembrolizumab (an immunotherapy) and mifepristone (a hormone blocker)—in people with advanced HER2-negative breast cancer. The goal was to see if the combination could shrink tumors. The study was stopped early after enrolling 24 parti…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Gut bacteria boosts cancer drug? early trial hints at possibility
Disease control Stopped earlyThis study tested whether taking a pill containing gut bacteria (EDP1503) could help the immunotherapy drug pembrolizumab (Keytruda) work better in people with advanced melanoma. The trial included two groups: those who had never received anti-PD1 therapy and those whose cancer h…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Can a lower dose of prostate cancer drug work just as well?
Disease control Stopped earlyThis study looked at whether men with prostate cancer could take a lower dose of the drug abiraterone (combined with prednisone) and still control their cancer. About 50 men who had never taken abiraterone before were enrolled. The goal was to find the smallest dose that still lo…
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Quick MRI scan could spot breast cancer earlier in dense breasts
Diagnosis Stopped earlyThis study tested a new, fast, and low-cost MRI method for breast cancer screening in women with dense breasts or moderate risk. The goal was to see if this MRI could find cancers earlier and more accurately than standard mammograms. The study enrolled 166 women and compared MRI …
Sponsor: University of Chicago • Aim: Diagnosis
Last updated Jun 27, 2026 11:04 UTC
-
Heart surgery recovery: can patients manage their own precautions?
Symptom relief Stopped earlyThis study looked at whether letting patients manage their own recovery precautions after heart surgery leads to a better quality of life compared to following standard sternal precautions. Ten adults who had heart surgery were followed for up to a year. Researchers checked pain,…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Leg traction before surgery: does it help or not?
Symptom relief Stopped earlyThis study looked at whether using skeletal traction (a gentle pull on the leg) before surgery for a broken thigh bone makes the operation easier and reduces pain and blood loss. It included 18 adults who had surgery within 24 hours of their injury. The study was stopped early, s…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Glutathione study for autism fizzles out early
Symptom relief Stopped earlyThis study aimed to see if taking glutathione by mouth is safe and practical for children and teens with autism. Researchers planned to enroll 24 participants but stopped early with only 6. The goal was to measure changes in behavior and social skills over 12 weeks.
Phase 4 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 26, 2026 18:02 UTC
-
Breathlessness mystery: can a finger device predict side effects in myeloma treatment?
Knowledge-focused Stopped earlyThis study aimed to find out why some multiple myeloma patients develop shortness of breath when taking the drug carfilzomib. Researchers used an FDA-approved finger device called EndoPAT to check blood vessel health and tracked symptoms through surveys. The study enrolled 50 adu…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Scientists hunt for hidden family genes behind painful skin disease
Knowledge-focused Stopped earlyThis study aimed to find a genetic link or family trait that connects people with Hidradenitis Suppurativa (HS), a painful skin condition. Researchers collected blood or saliva samples from 97 participants, including affected individuals and their family members, to analyze DNA f…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC